{
  "id": "7394341c4a50b7ed",
  "title": "Bispecific Antibodies in Multiple Myeloma : ASH 2025 Highlights",
  "description": "20251215T210000Z",
  "content": "",
  "source": "cancertherapyadvisor.com",
  "source_url": "https://www.cancertherapyadvisor.com/features/bispecific-antibodies-in-multiple-myeloma-ash-2025/",
  "published_at": "20251215T210000Z",
  "fetched_at": "2025-12-16T00:23:22.810654+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.cancertherapyadvisor.com/features/bispecific-antibodies-in-multiple-myeloma-ash-2025/",
    "url_mobile": "",
    "title": "Bispecific Antibodies in Multiple Myeloma : ASH 2025 Highlights",
    "seendate": "20251215T210000Z",
    "socialimage": "https://www.cancertherapyadvisor.com/wp-content/uploads/sites/12/2025/12/ASH_Orlando_2025_F.jpg",
    "domain": "cancertherapyadvisor.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}